CN Patent

CN112367998B — 用组胺-3受体反向激动剂进行治疗的方法

Assigned to Suven Life Sciences Ltd · Expires 2024-05-28 · 2y expired

What this patent protects

本发明提供了通过施用治疗有效量的组胺‑3受体(H 3 R)反向激动剂N‑[4‑(1‑环丁基哌啶‑4‑基氧基)苯基]‑2‑(吗啉‑4‑基)乙酰胺或其可药用盐来治疗发作性睡病、日间过度嗜睡、阻塞性睡眠呼吸暂停、昼夜节律性睡眠障碍，与帕金森病、多发性硬化、痴呆或注意缺陷多动障碍相关的睡眠和警觉障碍的新方法。本发明还提供了所述化合物在制备旨在用于治疗本文中所述病症的药物中的用途。

USPTO Abstract

本发明提供了通过施用治疗有效量的组胺‑3受体(H 3 R)反向激动剂N‑[4‑(1‑环丁基哌啶‑4‑基氧基)苯基]‑2‑(吗啉‑4‑基)乙酰胺或其可药用盐来治疗发作性睡病、日间过度嗜睡、阻塞性睡眠呼吸暂停、昼夜节律性睡眠障碍，与帕金森病、多发性硬化、痴呆或注意缺陷多动障碍相关的睡眠和警觉障碍的新方法。本发明还提供了所述化合物在制备旨在用于治疗本文中所述病症的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN112367998B
Jurisdiction: CN
Classification: —
Expires: 2024-05-28
Drug substance claim: No
Drug product claim: No
Assignee: Suven Life Sciences Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.